A new study published in the Journal of American Medical Association showed that postacute sequelae of SARS-CoV-2 (PASC) were more common in patients with schizophrenia, bipolar illness, or recurrent major depressive disorder, illuminating the necessity for integrated mental health and COVID-19 care regimens.

It is uncertain if those with a serious mental illness (SMI) are more likely to have postacute sequelae of SARS-CoV-2 (PASC), given their greater susceptibility to COVID-19. Secondary prevention initiatives might benefit from an understanding of this connection. Thus, this study determined the risk that individuals with a SMI will acquire PASC.

Data from extensive electronic health records (EHRs) between March 2020 and April 2023, including a 180-day follow-up, were used in this

See Full Page